Vanberra Signal

CardioMEMS

Curated by Signal

Wireless sensor-based cardiac implants

Overview

CardioMEMS develops and commercializes a wireless sensing and communication technology for the heart. The company's technology improves the management of chronic cardiovascular diseases, such as heart failure(, hypertension, and aneurysms. The company’s miniature wireless sensors are implanted using minimally invasive techniques, which transmit cardiac output, blood pressure, and heart rate data. Its products include the CardioMEMS HF System and EndoSure Wireless AAA Pressure Measurement System that is inserted during the minimally invasive endovascular repair of abdominal aortic aneurysms or AAA through a catheter into a patient's aneurysm sac, which measures and communicates pressure information to an external electronics module from inside the sac.

Key facts

Founded
2001

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More High Technology companies
  • Provider of AI-based platform that offer mental health support to employees and patients

    High TechnologySan Francisco, United States
  • Video analytics solutions provider

    High TechnologySan Diego, United States
  • Developer of an AI-based human avatar generation platform

    High TechnologyPalo Alto, United States

About CardioMEMS

What does CardioMEMS do?

CardioMEMS develops and commercializes a wireless sensing and communication technology for the heart.

Where is CardioMEMS headquartered?

CardioMEMS is headquartered in Atlanta, United States.

When was CardioMEMS founded?

CardioMEMS was founded in 2001.

Which sector is CardioMEMS in?

CardioMEMS operates in High Technology.

Who are CardioMEMS's competitors?

Companies similar to CardioMEMS include Cass, Prism Analytics, and DeepBrain.